Literature DB >> 24688776

Imaging techniques for tumour delineation and heterogeneity quantification of lung cancer: overview of current possibilities.

Wouter van Elmpt1, Catharina M L Zegers1, Marco Das1, Dirk De Ruysscher1.   

Abstract

Imaging techniques for the characterization and delineation of primary lung tumours and lymph nodes are a prerequisite for adequate radiotherapy. Numerous imaging modalities have been proposed for this purpose, but only computed tomography (CT) and FDG-PET have been implemented in clinical routine. Hypoxia PET, dynamic contrast-enhanced CT (DCE-CT), dual energy CT (DECT) and (functional) magnetic resonance imaging (MRI) hold promise for the future. Besides information on the primary tumour, these techniques can be used for quantification of tissue heterogeneity and response. In the future, treatment strategies may be designed which are based on imaging techniques to optimize individual treatment.

Entities:  

Keywords:  Lung cancer; heterogeneity; imaging; tumour delineation

Year:  2014        PMID: 24688776      PMCID: PMC3968562          DOI: 10.3978/j.issn.2072-1439.2013.08.62

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  101 in total

1.  Comparison of 18F-Fluoroerythronitroimidazole and 18F-fluorodeoxyglucose positron emission tomography and prognostic value in locally advanced non-small-cell lung cancer.

Authors:  Ling Li; Man Hu; Hui Zhu; Wei Zhao; Guoren Yang; Jinming Yu
Journal:  Clin Lung Cancer       Date:  2010-09-01       Impact factor: 4.785

2.  The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer.

Authors:  Wouter van Elmpt; Dirk De Ruysscher; Anke van der Salm; Annemarie Lakeman; Judith van der Stoep; Daisy Emans; Eugène Damen; Michel Öllers; Jan-Jakob Sonke; José Belderbos
Journal:  Radiother Oncol       Date:  2012-04-06       Impact factor: 6.280

3.  Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer.

Authors:  Frank J Lagerwaard; Cornelis J A Haasbeek; Egbert F Smit; Ben J Slotman; S Senan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-12-31       Impact factor: 7.038

4.  Radiation-induced reductions in regional lung perfusion: 0.1-12 year data from a prospective clinical study.

Authors:  Junan Zhang; Jinli Ma; Sumin Zhou; Jessica L Hubbs; Terence Z Wong; Rodney J Folz; Elizabeth S Evans; Ronald J Jaszczak; Robert Clough; Lawrence B Marks
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-07-23       Impact factor: 7.038

5.  Dual-energy CT based vascular iodine analysis improves sensitivity for peripheral pulmonary artery thrombus detection: an experimental study in canines.

Authors:  Chun Xiang Tang; Long Jiang Zhang; Zong Hong Han; Chang Sheng Zhou; Aleksander W Krazinski; Justin R Silverman; U Joseph Schoepf; Guang Ming Lu
Journal:  Eur J Radiol       Date:  2013-07-26       Impact factor: 3.528

6.  Feasibility of pathology-correlated lung imaging for accurate target definition of lung tumors.

Authors:  Joep Stroom; Hans Blaauwgeers; Angela van Baardwijk; Liesbeth Boersma; Joos Lebesque; Jacqueline Theuws; Robert-Jan van Suylen; Houke Klomp; Koen Liesker; Renée van Pel; Christian Siedschlag; Kenneth Gilhuijs
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-09-01       Impact factor: 7.038

7.  Dual-energy CT lung ventilation/perfusion imaging for diagnosing pulmonary embolism.

Authors:  Long Jiang Zhang; Chang Sheng Zhou; U Joseph Schoepf; Hui Xue Sheng; Sheng Yong Wu; Aleksander W Krazinski; Justin R Silverman; Felix G Meinel; Yan E Zhao; Zong Jun Zhang; Guang Ming Lu
Journal:  Eur Radiol       Date:  2013-06-13       Impact factor: 5.315

8.  PET imaging of tumor hypoxia using 18F-fluoroazomycin arabinoside in stage III-IV non-small cell lung cancer patients.

Authors:  Vikram R Bollineni; Gerald S M A Kerner; Jan Pruim; Roel J H M Steenbakkers; Erwin M Wiegman; Michel J B Koole; Eleonore H de Groot; Antoon T M Willemsen; Gert Luurtsema; Joachim Widder; Harry J M Groen; Johannes A Langendijk
Journal:  J Nucl Med       Date:  2013-06-10       Impact factor: 10.057

Review 9.  Hypoxia imaging using Positron Emission Tomography in non-small cell lung cancer: implications for radiotherapy.

Authors:  Vikram Rao Bollineni; Erwin M Wiegman; Jan Pruim; Harry J M Groen; Johannes A Langendijk
Journal:  Cancer Treat Rev       Date:  2012-05-04       Impact factor: 12.111

10.  Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer.

Authors:  Daniela Thorwarth; Susanne-Martina Eschmann; Jutta Scheiderbauer; Frank Paulsen; Markus Alber
Journal:  BMC Cancer       Date:  2005-12-01       Impact factor: 4.430

View more
  8 in total

1.  Overcoming the hurdles of using PET/CT for target volume delineation in curative intent radiotherapy of non-small cell lung cancer.

Authors:  Leila Tchelebi; Hani Ashamalla
Journal:  Ann Transl Med       Date:  2015-08

Review 2.  Biological imaging in clinical oncology: radiation therapy based on functional imaging.

Authors:  Yo-Liang Lai; Chun-Yi Wu; K S Clifford Chao
Journal:  Int J Clin Oncol       Date:  2016-07-06       Impact factor: 3.402

3.  Combined use of (18)F-FDG and (18)F-FMISO in unresectable non-small cell lung cancer patients planned for radiotherapy: a dynamic PET/CT study.

Authors:  Christos Sachpekidis; Christian Thieke; Vasileios Askoxylakis; Nils H Nicolay; Peter E Huber; Michael Thomas; Georgia Dimitrakopoulou; Juergen Debus; Uwe Haberkorn; Antonia Dimitrakopoulou-Strauss
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-01-15

4.  Clinical respiratory motion correction software (reconstruct, register and averaged-RRA), for 18F-FDG-PET-CT: phantom validation, practical implications and patient evaluation.

Authors:  Anne-Charlotte Bouyeure-Petit; Mathieu Chastan; Agathe Edet-Sanson; Stephanie Becker; Sebastien Thureau; Estelle Houivet; Pierre Vera; Sebastien Hapdey
Journal:  Br J Radiol       Date:  2017-01-03       Impact factor: 3.039

5.  Dual-Phase Dual-Energy CT in Patients Treated with Erlotinib for Advanced Non-Small Cell Lung Cancer: Possible Benefits of Iodine Quantification in Response Assessment.

Authors:  Jan Baxa; Tana Matouskova; Gabriela Krakorova; Bernhard Schmidt; Thomas Flohr; Martin Sedlmair; Jiri Bejcek; Jiri Ferda
Journal:  Eur Radiol       Date:  2015-11-12       Impact factor: 5.315

Review 6.  Functional imaging for radiotherapy treatment planning: current status and future directions-a review.

Authors:  D Thorwarth
Journal:  Br J Radiol       Date:  2015-04-01       Impact factor: 3.039

Review 7.  [Quantitative Imaging Assessment of Tumor Response to Chemoradiation 
in Lung Cancer].

Authors:  Yuxin Jiao; Yanping Ren; Xiangpeng Zheng
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2017-06-20

8.  Multiparametric imaging of patient and tumour heterogeneity in non-small-cell lung cancer: quantification of tumour hypoxia, metabolism and perfusion.

Authors:  Wouter van Elmpt; Catharina M L Zegers; Bart Reymen; Aniek J G Even; Anne-Marie C Dingemans; Michel Oellers; Joachim E Wildberger; Felix M Mottaghy; Marco Das; Esther G C Troost; Philippe Lambin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-09-04       Impact factor: 9.236

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.